Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ADJUTEC PHARMA AS
AS
Active
Org 923831762
Ullernchausséen 64, 0379
Oslo
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2019 · 6 years old
5 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ADJUTEC PHARMA AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
0M
2M
5M
7M
9M
0M
2020
6M
2021
8M
2022
7M
2023
0M
2024
EBITDA
NOK millions
0M
-7M
-14M
-22M
-29M
-1M
2020
-5M
-400%
2021
-23M
-360%
2022
-13M
+43%
2023
-2M
+85%
2024
Income statement
NOK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
6 278
7 842
7 333
0
Staff expenses
−0
−1 631
−5 157
−5 914
−6 952
EBITDA
−747
−5 216
−23 395
−13 047
−2 100
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−747
−5 216
−23 395
−13 047
−2 100
Net financials
−0
−183
173
−169
220
Profit before tax
−747
−5 399
−23 222
−13 215
−1 881
Tax
−0
−1 883
−6 072
−3 681
−426
Net profit
−747
−3 516
−17 151
−9 534
−1 455
Balance sheet
NOK thousands
Item
2020
2021
2022
2023
2024
Total assets
1 541
32 987
33 992
18 091
43 418
Equity
1 277
32 760
27 601
18 067
33 345
Long-term debt
0
0
0
0
0
Short-term debt
263
227
6 391
24
−966
Total debt
263
227
6 391
24
−966
Financial ratios
5-year trend
EBITDA margin
-210042000.0%
This company
15.8%
Market median
-1329379847% vs market
2020
2024
Equity ratio
76.8%
This company
38.2%
Market median
+101% vs market
2020
2024
Return on equity
-4.4%
This company
18.4%
Market median
-124% vs market
2020
2024
Net profit margin
-145502200.0%
This company
8.1%
Market median
-1796323557% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on ADJUTEC PHARMA AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
